Page 2,268«..1020..2,2672,2682,2692,270..2,2802,290..»

ACMG Foundation announces inaugural recipient of Lovell Award

Posted: Published on March 31st, 2015

The ACMG Foundation for Genetic and Genomic Medicine announces the first recipient of the ACMG Foundation Carolyn Mills Lovell Award at the 2015 ACMG Annual Clinical Genetics Meeting in Salt Lake City, Utah: First award specifically for genetic counselors Stephanie Harris, CGC was honored as the first recipient of the ACMG Foundation Carolyn Mills Lovell Award at the American College of Medical Genetics and Genomics (ACMG) 2015 Annual Clinical Genetics Meeting in Salt Lake City, Utah. Ms. Harris was selected to receive the award for her poster presentation, "The Impact of Variant Reclassification on Hypertrophic Cardiomyopathy Research". Ms. Harris completed her Masters of Science in Human Genetics and Genetic Counseling at Stanford University School of Medicine in Stanford, CA. and her Bachelor of Science in Biology at Bucknell University in Lewisburg, PA. She is currently a genetic counselor in Cardiovascular Genetics at Brigham and Women's Hospital in Boston, MA. This award was made possible due to a generous donation by ACMG Medical Director David Flannery, MD, FAAP, FACMG to honor genetic counselor Carolyn Mills Lovell, MAT, MS, CGC. Dr. Flannery worked with Ms. Lovell for over 15 years while he was at the Medical College of Georgia (MCG) of Georgia … Continue reading →

Posted in Genetics | Comments Off on ACMG Foundation announces inaugural recipient of Lovell Award

Illuminati Science EXPOSED Genetic Engineering, Cloning, DNA Manipulation, Transhumanism 1080p – Video

Posted: Published on March 31st, 2015

Illuminati Science EXPOSED Genetic Engineering, Cloning, DNA Manipulation, Transhumanism 1080p I am just a middleman trying to spread the word FAIR USE NOTICE: This video may contain copyrighted material. Such material is made available for entertainment purposes only. This constitutes... By: Timothy anon … Continue reading →

Posted in Genetic Engineering | Comments Off on Illuminati Science EXPOSED Genetic Engineering, Cloning, DNA Manipulation, Transhumanism 1080p – Video

What is Genetic Engineering? – Video

Posted: Published on March 31st, 2015

What is Genetic Engineering? Learn about how genetic engineering works and how it can be applied in science. By: Eco-Wise Videos … Continue reading →

Posted in Genetic Engineering | Comments Off on What is Genetic Engineering? – Video

Genetic Engineering Video 678 – Video

Posted: Published on March 31st, 2015

Genetic Engineering Video 678 By: SimonFichterMSD … Continue reading →

Posted in Genetic Engineering | Comments Off on Genetic Engineering Video 678 – Video

Can caffeine be used to treat or prevent Alzheimer’s disease?

Posted: Published on March 31st, 2015

IMAGE:Journal of Caffeine Research covers the effects of caffeine on a wide range of diseases and conditions, including mood disorders, neurological disorders, cognitive performance, cardiovascular disease, and sports performance.... view more Credit: (c) 2015 Mary Ann Liebert, Inc., publishers New Rochelle, NY, March 31, 2015-The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Caffeine Research website at http://online.liebertpub.com/doi/full/10.1089/jcr.2014.0027 until May 1, 2015. In the article "Caffeine as Treatment for Alzheimer's: A Review", Abhishek Mohan, BS, Old Dominion University (Norfolk, VA), and coauthors identify the potential opportunities for using caffeine to reduce beta amyloid levels as a means of preventing, treating, and slowing the progression of Alzheimer's disease. "To say that strategizing medicines to treat Alzheimer's disorders is important is an understatement," says Patricia A. Broderick, PhD, Editor-in-Chief … Continue reading →

Posted in Genetic Engineering | Comments Off on Can caffeine be used to treat or prevent Alzheimer’s disease?

What is the best measure of depression severity in adolescents?

Posted: Published on March 31st, 2015

IMAGE:Journal of Child and Adolescent Psychopharmacology (JCAP), celebrating 25 years in 2015, is an authoritative peer-reviewed journal published 10 times a year in print and online. The Journal... view more Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, March 30, 2015--At present the key symptom for diagnosing major depressive disorder (MDD) in adolescents is irritability. However a new study has found that the severity of anhedonia (the inability to gain pleasure from experiences that usually are enjoyable) rather than of irritability is associated with more severe MDD and worse clinical outcomes and suicide scores. Results of the study are published in Journal of Child and Adolescent Psychopharmacology (JCAP), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, and is available free on the JCAP website until April 30, 2015. Vilma Gabbay, MD, and coauthors at Icahn School of Medicine at Mount Sinai and New York University Langone Medical Center (New York, NY), and Nathan S. Kline Institute for Psychiatric Research (Orangeburg, NY), used a quantitative approach to focus on symptoms of irritability and anhedonia simultaneously in 90 adolescents with MDD. Only anhedonia severity showed a significant correlation with the severity of overall outcomes, including illness severity, episode duration, and … Continue reading →

Posted in Genetic Engineering | Comments Off on What is the best measure of depression severity in adolescents?

DNA GENE THERAPY – Video

Posted: Published on March 31st, 2015

DNA GENE THERAPY Vision restored to patient with DNA GENE THERAPY. By: sunita agarwal … Continue reading →

Posted in Gene Therapy | Comments Off on DNA GENE THERAPY – Video

GENE THERAPY FOR GENETIC EYE DISORDERS – Video

Posted: Published on March 31st, 2015

Posted in Gene Therapy | Comments Off on GENE THERAPY FOR GENETIC EYE DISORDERS – Video

Biotech’s next buzz: Gene therapy?

Posted: Published on March 31st, 2015

Imagine if instead of using drugs or surgery, a doctor could simply insert a gene into a patient's cell to treat or prevent disease. Gene therapy is endeavoring to do just that and could emerge in the coming years as a viable alternative for treatment. Certain conditions that previously couldn't be treated, such as forms of blindness, types of cancer or more rare conditions like sickle cell disease are now being researched with this alternative treatment. Phil Nadeau, biotechnology analyst with Cowen and Company, predicts there will be several gene therapy products approved by the F.D.A. within the next few years. He told CNBC recently he sees more than $1 billion in gene therapy sales worldwide, which ultimately means significant investments in gene therapy in the near future. "In the past, most major companies stayed away from having gene therapy programs. In the future, we think, it's going to be a standard treatment," he said. Link: Biotech's next buzz: Gene therapy? … Continue reading →

Posted in Gene Therapy | Comments Off on Biotech’s next buzz: Gene therapy?

Cancer gene therapy biotech MultiVir files for a $70 million IPO

Posted: Published on March 31st, 2015

MultiVir, a biotech developing gene therapies for cancer, filed on Monday with the SEC to raise up to $70 million in an initial public offering. The Houston, TX-based company, which was founded in 2009, plans to list on the NASDAQ under the symbol MVIR. MultiVir initially filed confidentially on December 22, 2014. RBC Capital Markets is the sole bookrunner on the deal. No pricing terms were disclosed. Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc. Original post: Cancer gene therapy biotech MultiVir files for a $70 million IPO … Continue reading →

Posted in Gene Therapy | Comments Off on Cancer gene therapy biotech MultiVir files for a $70 million IPO

Page 2,268«..1020..2,2672,2682,2692,270..2,2802,290..»